Marina R. Von Essen

Glostrup, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

CSF Leukocytes Transiently Increase Before Onset of Huntington Disease in Association With a Stage-Specific CSF Cytokine/Chemokine Pattern.

CSF Leukocytes Transiently Increase Before Onset of Huntington Disease in Association With a Stage-Specific CSF Cytokine/Chemokine Pattern.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 17, 2026

Blood-brain barrier integrity and prevalence of intrathecal T helper 17.1 cells in Huntington´s disease.

Blood-brain barrier integrity and prevalence of intrathecal T helper 17.1 cells in Huntington´s disease.

Journal: PloS one

Published: July 10, 2025

A role for DICAM+ mononuclear phagocytes in controlling neuroinflammation in multiple sclerosis.

A role for DICAM+ mononuclear phagocytes in controlling neuroinflammation in multiple sclerosis.

Journal: Frontiers in immunology

Published: May 14, 2025

Corrigendum to "Cerebrospinal fluid soluble CD27 is associated with CD8+ T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis" [Journal of neuroimmunology vol. 381 (2023): 578128].

Corrigendum to "Cerebrospinal fluid soluble CD27 is associated with CD8+ T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis" [Journal of neuroimmunology vol. 381 (2023): 578128].

Journal: Journal of neuroimmunology

Published: April 11, 2025

Mononuclear phagocytes in blood and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis: Untreated and treated with anti-CD20 therapy.

Mononuclear phagocytes in blood and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis: Untreated and treated with anti-CD20 therapy.

Journal: Journal of neuroimmunology

Published: April 08, 2025

A role of CD20+ T cells in early multiple sclerosis.

A role of CD20+ T cells in early multiple sclerosis.

Journal: Frontiers in immunology

Published: February 24, 2025

Chitinase-1 in cerebrospinal fluid and white matter injury in patients with progressive multiple sclerosis.

Chitinase-1 in cerebrospinal fluid and white matter injury in patients with progressive multiple sclerosis.

Journal: Journal of neuroimmunology

Published: December 03, 2024

The origin of human CD20+ T cells: a stolen identity?

The origin of human CD20+ T cells: a stolen identity?

Journal: Frontiers in immunology

Published: August 28, 2024

Profiling of B cells and their subsets by whole blood gene expression analysis versus flow cytometry in multiple sclerosis.

Profiling of B cells and their subsets by whole blood gene expression analysis versus flow cytometry in multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: July 11, 2024

Effects of anti-CD20 therapy on circulating and intrathecal follicular helper T cell subsets in multiple sclerosis.

Effects of anti-CD20 therapy on circulating and intrathecal follicular helper T cell subsets in multiple sclerosis.

Journal: Clinical immunology (Orlando, Fla.)

Published: February 28, 2024

Sustained effects on immune cell subsets and autoreactivity in multiple sclerosis patients treated with oral cladribine.

Sustained effects on immune cell subsets and autoreactivity in multiple sclerosis patients treated with oral cladribine.

Journal: Frontiers in immunology

Published: October 25, 2023

CD11c+ B cells in relapsing-remitting multiple sclerosis and effects of anti-CD20 therapy.

CD11c+ B cells in relapsing-remitting multiple sclerosis and effects of anti-CD20 therapy.

Journal: Annals of clinical and translational neurology

Published: October 12, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026